Literature DB >> 7953396

Randomized comparison of fine-needle aspiration cytology and Biopty-Cut needle biopsy after unsatisfactory initial cytology of discrete breast lesions.

N J Carty1, D Ravichandran, C Carter, S Mudan, G T Royle, I Taylor.   

Abstract

In a minority of patients with a discrete breast lump the initial cytological assessment is either unsatisfactory or at variance with the results of other methods of diagnosis. A randomized comparison of repeat cytology and needle-core biopsy provided clinically useful information in 14 of 31 patients receiving repeat cytology and in 26 of 29 randomized to core biopsy. Nineteen patients had carcinoma: ten who received repeat cytology, which indicated malignancy in only three (diagnostic of malignancy in one, suspicious in two), while all nine patients who underwent core biopsy had a correct diagnosis (only suspicious of malignancy in one). The sensitivity for the definitive diagnosis of carcinoma on repeat cytology and core biopsy was 10 and 89 per cent respectively. Patients with a discrete breast lump and unclear cytology results require needle-core biopsy. This has more diagnostic value than repeat cytology.

Entities:  

Mesh:

Year:  1994        PMID: 7953396     DOI: 10.1002/bjs.1800810917

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer.

Authors:  D Clarke; N Sudhakaran; C A Gateley
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Ultrasound-guided Tru-cut biopsy of the breast.

Authors:  N P Woodcock; I Glaves; D R Morgan; J MacFie
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

3.  Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma.

Authors:  A Zidan; J S Christie Brown; D Peston; S Shousha
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.